The organizations that will thrive in this environment are those that invest in resilience — the capacity to adapt, absorb strain, and maintain performance in the face of volatility.
As the pharmaceutical landscape evolves, small-molecule CDMOs will be essential in balancing supply and demand, driving innovation, and improving patient outcomes. They must continue embracing innovation and strategic agility to survive and thrive in this complex environment.
Help shape the future of healthcare benefits by sharing your insights.
Along with daily surveys, a research team from Mount Sinai used Apple Watches to measure how stress impacted healthcare workers' bodies and pinpointed the characteristics that were associated with lower stress levels over time.